Trials / Unknown
UnknownNCT03796104
Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- —
Summary
The aim of this study is to determine if delta-haemolysin production deficiency of Staphylococcus aureus is a marker in favour of chronic infections on implants
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Delta-haemolysin | comparison of groups having infection with S. aureus with and without delta-haemolysin Production |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2018-12-31
- Completion
- 2023-12-31
- First posted
- 2019-01-08
- Last updated
- 2023-04-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03796104. Inclusion in this directory is not an endorsement.